Ancora Advisors »

Medite Cancer Diagnostics shares owned by Ancora Advisors

Quarter-by-quarter ownership of Medite Cancer Diagnostics (MDIT) shares owned by Ancora Advisors from 13F filings

Historical chart of Ancora Advisors investment in Medite Cancer Diagnostics

Tip: Access up to 7 years of quarterly data

All positions including Medite Cancer Diagnostics held by Ancora Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Medite Cancer Diagnostics by Ancora Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $0 30 0.00
2025-09-30 $0 30 0.00
2025-06-30 $0 30 0.00

More positions owned by Ancora Advisors

LKQ Corporation (LKQ)
Broadcom (AVGO)
Apple (AAPL)
Americold Rlty Tr (COLD)
Vanguard S&p 500 Etf Indx Fd (VOO)
Rb Global (RBA)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Total U S Indx Fd (ITOT)
JPMorgan Chase & Co. (JPM)
Jp Morgan Ultra Short Income E Indx Fd (JPST)
Abbvie (ABBV)
Ishares Tr Core S&p500 Etf Indx Fd (IVV)
Eaton (ETN)
Johnson & Johnson (JNJ)
Alphabet Inc Class C cs (GOOG)

View all positions for Ancora Advisors

Top funds holding Medite Cancer Diagnostics

Ancora Advisors

View all funds holding Medite Cancer Diagnostics